| 000 | 01330 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513040007.0 | ||
| 264 | 0 | _c19951018 | |
| 008 | 199510s 0 0 eng d | ||
| 022 | _a0033-3158 | ||
| 024 | 7 |
_a10.1007/BF02246290 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWalsh, S L | |
| 245 | 0 | 0 |
_aEffects of buprenorphine and methadone in methadone-maintained subjects. _h[electronic resource] |
| 260 |
_bPsychopharmacology _cJun 1995 |
||
| 300 |
_a268-76 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBuprenorphine _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethadone _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOpioid-Related Disorders _xrehabilitation |
| 650 | 0 | 4 |
_aSubstance Withdrawal Syndrome _xetiology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aJune, H L | |
| 700 | 1 | _aSchuh, K J | |
| 700 | 1 | _aPreston, K L | |
| 700 | 1 | _aBigelow, G E | |
| 700 | 1 | _aStitzer, M L | |
| 773 | 0 |
_tPsychopharmacology _gvol. 119 _gno. 3 _gp. 268-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02246290 _zAvailable from publisher's website |
| 999 |
_c7675388 _d7675388 |
||